Addressing barriers in comprehensiveness, accessibility, reusability, interoperability and reproducibility of computational models in systems biology.
Autorzy:
Niarakis A; Université Paris-Saclay, Laboratoire Européen de Recherche pour la Polyarthrite rhumatoïde - Genhotel, Univ Evry, Evry, France.; Lifeware Group, Inria, Saclay-île de France, 91120 Palaiseau, France. Waltemath D; Department of Medical Informatics, University Medicine Greifswald, Greifswald, Germany. Glazier J; Biocomplexity Institute and Department of Intelligent Systems Engineering, Indiana University, Bloomington, IN, USA. Schreiber F; Department of Computer and Information Science, University of Konstanz, Konstanz, Germany.; Faculty of Information Technology, Monash University, Clayton, Australia. KeatingSM; University College London, London, United Kingdom. Nickerson D; Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand. Chaouiya C; Aix Marseille Univ, CNRS, I2M, Marseille, France. Siegel A; Univ Rennes, CNRS, Inria - IRISA lab. Rennes. Noël V; Institut Curie, PSL Research University, Paris, France.; INSERM, U900, Paris, France.; MINES ParisTech, PSL Research University, CBIO-Centre for Computational Biology, Paris, France. Hermjakob H; EMBL-European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK. Helikar T; Department of Biochemistry, University of Nebraska-Lincoln, Lincoln, NE, 68588, USA. Soliman S; Lifeware Group, Inria, Saclay-île de France, 91120 Palaiseau, France. Calzone L; Institut Curie, PSL Research University, Paris, France.; INSERM, U900, Paris, France.; MINES ParisTech, PSL Research University, CBIO-Centre for Computational Biology, Paris, France.
Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.
Autorzy:
Gisslen M; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Infectious Diseases, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden. KeatingSM; Vitalant Research Institute (formerly Blood Systems Research Institute), San Francisco, CA, United States of America. Spudich S; Department of Neurology, Yale University School of Medicine, New Haven, CT, United States of America. Arechiga V; Department of Neurology, University of California San Francisco, San Francisco, CA, United States of America. Stephenson S; Department of Neurology, University of California San Francisco, San Francisco, CA, United States of America. Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, United Kingdom.; UK Dementia Research Institute at UCL, London, United Kingdom. Di Germanio C; Vitalant Research Institute (formerly Blood Systems Research Institute), San Francisco, CA, United States of America. Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. Fuchs D; Institute of Biological Chemistry, Innsbruck Medical University, Innsbruck, Austria. Hagberg L; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Norris PJ; Vitalant Research Institute (formerly Blood Systems Research Institute), San Francisco, CA, United States of America. Peterson J; Department of Neurology, University of California San Francisco, San Francisco, CA, United States of America. Shacklett BL; Department of Medical Microbiology and Immunology, University of California Davis, Davis CA, United States of America. Yiannoutsos CT; Department of Biostatistics, Indiana University R.M. Fairbanks School of Public Health, Indianapolis, IN, United States of America. Price RW; Department of Neurology, University of California San Francisco, San Francisco, CA, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 May 13; Vol. 16 (5), pp. e0250987. Date of Electronic Publication: 2021 May 13 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
SBML Level 3: an extensible format for the exchange and reuse of biological models.
Autorzy:
KeatingSM; Computing and Mathematical Sciences, California Institute of Technology, Pasadena, CA, USA.; European Bioinformatics Institute, European Molecular Biology Laboratory (EMBL-EBI), Hinxton, UK.; BioQuant/COS, Heidelberg University, Heidelberg, Germany. Waltemath D; Medical Informatics, Institute for Community Health, University Medicine Greifswald, Greifswald, Germany. König M; Institute for Theoretical Biology, Humboldt-University Berlin, Berlin, Germany. Zhang F; Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Dräger A; Computational Systems Biology of Infection and Antimicrobial-Resistant Pathogens, Institute for Biomedical Informatics (IBMI), University of Tübingen, Tübingen, Germany.; Department of Computer Science, University of Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), Tübingen, Germany. Chaouiya C; Aix-Marseille Université, CNRS, Centrale Marseille, Marseille, France.; Instituto Gulbenkian de Ciência, Oeiras, Portugal. Bergmann FT; BioQuant/COS, Heidelberg University, Heidelberg, Germany. Finney A; ANSYS UK Ltd, Milton Park, Oxfordshire, UK. Gillespie CS; School of Mathematics, Statistics and Physics, Newcastle University, Newcastle upon Tyne, UK. Helikar T; Department of Biochemistry, University of Nebraska-Lincoln, Lincoln, NE, USA. Hoops S; Biocomplexity Institute & Initiative, University of Virginia, Charlottesville, VA, USA. Malik-Sheriff RS; European Bioinformatics Institute, European Molecular Biology Laboratory (EMBL-EBI), Hinxton, UK. Moodie SL; Eight Pillars Ltd, Edinburgh, UK. Moraru II; Center for Cell Analysis and Modeling, UConn Health, Farmington, CT, USA. Myers CJ; Department of Electrical and Computer Engineering, University of Utah, Salt Lake City, UT, USA. Naldi A; Institut de Biologie de l'ENS (IBENS), Département de Biologie, École Normale Supérieure, CNRS, INSERM, Université PSL, Paris, France. Olivier BG; Computing and Mathematical Sciences, California Institute of Technology, Pasadena, CA, USA.; BioQuant/COS, Heidelberg University, Heidelberg, Germany.; SysBioLab, AIMMS, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands. Sahle S; BioQuant/COS, Heidelberg University, Heidelberg, Germany. Schaff JC; Applied BioMath, LLC, Concord, MA, USA. Smith LP; Computing and Mathematical Sciences, California Institute of Technology, Pasadena, CA, USA.; Department of Bioengineering, University of Washington, Seattle, WA, USA. Swat MJ; Simcyp (a Certara company), Sheffield, South Yorkshire, UK. Thieffry D; Institut de Biologie de l'ENS (IBENS), Département de Biologie, École Normale Supérieure, CNRS, INSERM, Université PSL, Paris, France. Watanabe L; Department of Electrical and Computer Engineering, University of Utah, Salt Lake City, UT, USA. Wilkinson DJ; School of Mathematics, Statistics and Physics, Newcastle University, Newcastle upon Tyne, UK.; The Alan Turing Institute, British Library, London, UK. Blinov ML; Center for Cell Analysis and Modeling, UConn Health, Farmington, CT, USA. Begley K; California Institute of Technology, Pasadena, CA, USA. Faeder JR; Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA, USA. Gómez HF; Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland. Hamm TM; Computational Systems Biology of Infection and Antimicrobial-Resistant Pathogens, Institute for Biomedical Informatics (IBMI), University of Tübingen, Tübingen, Germany.; Department of Computer Science, University of Tübingen, Tübingen, Germany. Inagaki Y; Management & IT Consulting Division, Mizuho Information & Research Institute, Inc., Tokyo, Japan. Liebermeister W; Université Paris-Saclay, INRAE, MaIAGE, Jouy-en-Josas, France. Lister AL; Oxford e-Research Centre (OeRC), Department of Engineering Science, University of Oxford, Oxford, UK. Lucio D; College of Sciences, NC State University, Raleigh, NC, USA. Mjolsness E; Department of Computer Science, University of California, Irvine, CA, USA. Proctor CJ; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK. Raman K; Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology (IIT) Madras, Chennai, India.; Initiative for Biological Systems Engineering (IBSE), IIT Madras, Chennai, India.; Robert Bosch Centre for Data Science and Artificial Intelligence (RBC-DSAI), IIT Madras, Chennai, India. Rodriguez N; The Babraham Institute, Cambridge, UK. Shaffer CA; Department of Computer Science, Virginia Tech, Blacksburg, VA, USA. Shapiro BE; Department of Mathematics, California State University, Northridge, CA, USA. Stelling J; Department of Biosystems Science and Engineering, SIB Swiss Institute of Bioinformatics, ETH Zürich, Basel, Switzerland. Swainston N; Institute of Integrative Biology, University of Liverpool, Liverpool, UK. Tanimura N; Science Solutions Division, Mizuho Information & Research Institute, Inc., Tokyo, Japan. Wagner J; IBM Research Australia, Melbourne, Vic., Australia. Meier-Schellersheim M; Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Sauro HM; Department of Bioengineering, University of Washington, Seattle, WA, USA. Palsson B; Department of Bioengineering, University of California San Diego, La Jolla, CA, USA. Bolouri H; Systems Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA. Kitano H; The Systems Biology Institute, Tokyo, Japan.; Okinawa Institute of Science and Technology, Okinawa, Japan. Funahashi A; Department of Biosciences and Informatics, Keio University, Yokohama, Kanagawa, Japan. Hermjakob H; European Bioinformatics Institute, European Molecular Biology Laboratory (EMBL-EBI), Hinxton, UK. Doyle JC; Computing and Mathematical Sciences, California Institute of Technology, Pasadena, CA, USA. Hucka M; Computing and Mathematical Sciences, California Institute of Technology, Pasadena, CA, USA.
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review
Influence of sickle cell disease on susceptibility to HIV infection.
Autorzy:
Kelly S; Vitalant Research Institute, San Francisco, CA, United States of America.; UCSF Benioff Children's Hospital Oakland, Oakland, CA, United States of America. Jacobs ES; Vitalant Research Institute, San Francisco, CA, United States of America. Stone M; Vitalant Research Institute, San Francisco, CA, United States of America. KeatingSM; Vitalant Research Institute, San Francisco, CA, United States of America. Lee TH; Vitalant Research Institute, San Francisco, CA, United States of America. Chafets D; Vitalant Research Institute, San Francisco, CA, United States of America. Heitman J; Vitalant Research Institute, San Francisco, CA, United States of America. Dimapasoc M; Vitalant Research Institute, San Francisco, CA, United States of America. Operskalski E; Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America. Hagar W; UCSF Benioff Children's Hospital Oakland, Oakland, CA, United States of America. Vichinsky E; UCSF Benioff Children's Hospital Oakland, Oakland, CA, United States of America. Busch MP; Vitalant Research Institute, San Francisco, CA, United States of America. Norris PJ; Vitalant Research Institute, San Francisco, CA, United States of America. Custer B; Vitalant Research Institute, San Francisco, CA, United States of America.
Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay.
Autorzy:
KeatingSM; Vitalant Research Institute, San Francisco, CA, United States of America.; Department of Laboratory Medicine, University of California, San Francisco, CA, United States of America. Rountree W; Duke Human Vaccine Institute, Duke University, Durham, NC, United States of America. Grebe E; Vitalant Research Institute, San Francisco, CA, United States of America.; Department of Laboratory Medicine, University of California, San Francisco, CA, United States of America. Pappas AL; Duke Human Vaccine Institute, Duke University, Durham, NC, United States of America. Stone M; Vitalant Research Institute, San Francisco, CA, United States of America.; Department of Laboratory Medicine, University of California, San Francisco, CA, United States of America. Hampton D; Vitalant Research Institute, San Francisco, CA, United States of America. Todd CA; Duke Human Vaccine Institute, Duke University, Durham, NC, United States of America. Poniewierski MS; Duke Human Vaccine Institute, Duke University, Durham, NC, United States of America. Sanchez A; Duke Human Vaccine Institute, Duke University, Durham, NC, United States of America. Porth CG; Duke Human Vaccine Institute, Duke University, Durham, NC, United States of America. Denny TN; Duke Human Vaccine Institute, Duke University, Durham, NC, United States of America. Busch MP; Vitalant Research Institute, San Francisco, CA, United States of America.; Department of Laboratory Medicine, University of California, San Francisco, CA, United States of America.
Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance.
Autorzy:
Sempa JB; DST-NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa. Welte A; DST-NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa. Busch MP; Vitalant Research Institute, San Francisco, CA, United States of America.; University of California San Francisco, San Francisco, CA, United States of America. Hall J; Public Health England, London, United Kingdom. Hampton D; Vitalant Research Institute, San Francisco, CA, United States of America. Facente SN; Vitalant Research Institute, San Francisco, CA, United States of America.; University of California San Francisco, San Francisco, CA, United States of America.; Facente Consulting, Richmond, CA, United States of America. KeatingSM; Vitalant Research Institute, San Francisco, CA, United States of America.; University of California San Francisco, San Francisco, CA, United States of America. Marson K; University of California San Francisco, San Francisco, CA, United States of America. Parkin N; Data First Consulting, Belmont, CA, United States of America. Pilcher CD; University of California San Francisco, San Francisco, CA, United States of America. Murphy G; Public Health England, London, United Kingdom. Grebe E; DST-NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa.; Vitalant Research Institute, San Francisco, CA, United States of America.; University of California San Francisco, San Francisco, CA, United States of America.
Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size.
Autorzy:
Rosenbloom DIS; Department of Systems Biology, Columbia University College of Physicians and Surgeons, New York, New York, United States of America.; Department of Biomedical Informatics, Columbia University College of Physicians and Surgeons, New York, New York, United States of America. Bacchetti P; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America. Stone M; Blood Systems Research Institute, San Francisco, California, United States of America. Deng X; Blood Systems Research Institute, San Francisco, California, United States of America. Bosch RJ; Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America. Richman DD; University of California San Diego, La Jolla, California, United States of America.; Veterans Affairs San Diego Healthcare System, San Diego, California, United States of America. Siliciano JD; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America. Mellors JW; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America. Deeks SG; Division of HIV, Infectious Diseases and Global Medicine, University of California San Francisco, San Francisco, California, United States of America. Ptak RG; Southern Research, Frederick, Maryland, United States of America. Hoh R; Division of HIV, Infectious Diseases and Global Medicine, University of California San Francisco, San Francisco, California, United States of America. KeatingSM; Blood Systems Research Institute, San Francisco, California, United States of America.; Division of HIV, Infectious Diseases and Global Medicine, University of California San Francisco, San Francisco, California, United States of America. Dimapasoc M; Blood Systems Research Institute, San Francisco, California, United States of America. Massanella M; University of California San Diego, La Jolla, California, United States of America. Lai J; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America. Sobolewski MD; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America. Kulpa DA; Southern Research, Frederick, Maryland, United States of America.; Department of Pediatrics, Emory University, Atlanta, Georgia, United States of America. Busch MP; Blood Systems Research Institute, San Francisco, California, United States of America.; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, United States of America.
Opportunities and Challenges in Implementation of Multiparameter Single Cell Analysis Platforms for Clinical Translation.
Autorzy:
KeatingSM; CCS Associates, San Jose, California, USA. Taylor DL; University of Pittsburgh Drug Discovery Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Plant AL; Biosystems and Biomaterials Division Materials Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, Maryland, USA. Litwack ED; Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland, USA. Kuhn P; University of Southern California, Los Angeles, California, USA. Greenspan EJ; Center for Strategic Scientific Initiatives, National Cancer Institute, Bethesda, Maryland, USA. Hartshorn CM; National Cancer Institute, Bethesda, Maryland, USA. Sigman CC; CCS Associates, San Jose, California, USA. Kelloff GJ; National Cancer Institute, Bethesda, Maryland, USA. Chang DD; Kite Pharma, Inc., Santa Monica, California, USA. Friberg G; Amgen, Thousand Oaks, California, USA. Lee JSH; Center for Strategic Scientific Initiatives, National Cancer Institute, Bethesda, Maryland, USA. Kuida K; Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts, USA.
Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study.
Autorzy:
Cummins NW; Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, United States of America. Rizza S; Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, United States of America. Litzow MR; Division of Hematology, Mayo Clinic, Rochester, Minnesota, United States of America. Hua S; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America. Lee GQ; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America. Einkauf K; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America. Chun TW; HIV Immunovirology Unit, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America. Rhame F; Abbott Northwestern Hospital, Allina Health, Minneapolis, Minnesota, United States of America.; Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, United States of America. Baker JV; Division of Infectious Diseases, Hennepin County Medical Center, Minneapolis, Minnesota, United States of America. Busch MP; Blood Systems Research Institute, San Francisco, California, United States of America.; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, United States of America. Chomont N; Centre de Recherche du CHUM, University of Montreal Hospital Centre, Montreal, Canada.; Department of Microbiology, Infectious Diseases and Immunology, University of Montreal, Montreal, Canada. Dean PG; Division of Transplantation Surgery, Mayo Clinic, Rochester, Minnesota, United States of America. Fromentin R; Centre de Recherche du CHUM, University of Montreal Hospital Centre, Montreal, Canada.; Department of Microbiology, Infectious Diseases and Immunology, University of Montreal, Montreal, Canada. Haase AT; Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, United States of America. Hampton D; Blood Systems Research Institute, San Francisco, California, United States of America. KeatingSM; Blood Systems Research Institute, San Francisco, California, United States of America.; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, United States of America. Lada SM; University of California, San Diego, San Diego, California, United States of America.; VA San Diego Healthcare System, San Diego, California, United States of America. Lee TH; Blood Systems Research Institute, San Francisco, California, United States of America. Natesampillai S; Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, United States of America. Richman DD; University of California, San Diego, San Diego, California, United States of America.; VA San Diego Healthcare System, San Diego, California, United States of America. Schacker TW; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, United States of America. Wietgrefe S; Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, United States of America. Yu XG; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.; Infectious Disease Division, Brigham and Women's Hospital, Boston, Massachusetts, United States of America. Yao JD; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America. Zeuli J; Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, United States of America. Lichterfeld M; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.; Infectious Disease Division, Brigham and Women's Hospital, Boston, Massachusetts, United States of America. Badley AD; Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, United States of America.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2017 Nov 28; Vol. 14 (11), pp. e1002461. Date of Electronic Publication: 2017 Nov 28 (Print Publication: 2017).
The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study.
Autorzy:
KeatingSM; Blood Systems Research Institute, San Francisco, California, United States of America.; Department of Laboratory Medicine, University of California San Francisco, California, United States of America. Dodge JL; Department of Surgery, UCSF, San Francisco, California, United States of America. Norris PJ; Blood Systems Research Institute, San Francisco, California, United States of America.; Department of Laboratory Medicine, University of California San Francisco, California, United States of America.; Department of Medicine, UCSF, San Francisco, California, United States of America. Heitman J; Blood Systems Research Institute, San Francisco, California, United States of America. Gange SJ; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America. French AL; CORE Center, Stroger Hospital of Cook County, Chicago, Illinois, United States of America. Glesby MJ; Department of Medicine, Division of Infectious Diseases, Weill Cornell Medical College, New York, New York, United States of America. Edlin BR; Department of Medicine, Division of Infectious Diseases, Weill Cornell Medical College, New York, New York, United States of America.; Department of Medicine, SUNY Downstate, Brooklyn, New York, United States of America. Latham PS; Department of Pathology and Medicine, George Washington University Medical Center, Washington DC, United States of America. Villacres MC; Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America. Greenblatt RM; Department of Pharmacology, UCSF, San Francisco, California, United States of America. Peters MG; Department of Medicine, UCSF, San Francisco, California, United States of America.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
